Author: He, Chaobin; Wang, Jun; Sun, Shuxin; Zhang, Yu; Li, Shengping
Title: Immunomodulatory Effect after Irreversible Electroporation in Patients with Locally Advanced Pancreatic Cancer Document date: 2019_5_12
ID: 1pbzbydu_15
Snippet: . . Patient Characteristics. In the present study, a total of 34 patients with LAPC were retrospectively included in this study. All patients have received IRE therapy. There were 18 (52.9%) female patients and 16 (47.1%) male patients. The median age was 59.5 years (range 45-73 years). Patient characteristics were summarized in Table 1 . Large size and moderate differentiation were the most commonly seen features of tumors. Most patients had low.....
Document: . . Patient Characteristics. In the present study, a total of 34 patients with LAPC were retrospectively included in this study. All patients have received IRE therapy. There were 18 (52.9%) female patients and 16 (47.1%) male patients. The median age was 59.5 years (range 45-73 years). Patient characteristics were summarized in Table 1 . Large size and moderate differentiation were the most commonly seen features of tumors. Most patients had lower values of inflammatory indexes, such as PLR, PI, and mGPS, while patients with higher values of NLR occupied the majority of all patients. For the whole study cohort, there were only 4 patients whose TBIL was higher than 100 umol/L. Complications after IRE treatment in patients with LAPC were also evaluated ( Table 2 ). The most frequently reported complications were pain (3 of 34 patients) and hypotension (3 of 34 patients).
Search related documents:
Co phrase search for related documents- female patient and large size: 1, 2, 3
- female patient and male patient: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49
- female patient and median age: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- female patient and patient majority: 1
- female patient and present study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- female patient and study cohort: 1, 2, 3, 4
- frequently report and present study: 1
- frequently report and study cohort: 1
- high value and inflammatory index: 1
- high value and large size: 1, 2
- high value and low value: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74
- high value and median age: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
- high value and moderate differentiation: 1
- high value and NLR high value: 1, 2, 3, 4, 5, 6, 7, 8, 9
- high value and present study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32
- high value and study cohort: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
- inflammatory index and median age: 1, 2
- inflammatory index and present study: 1, 2, 3, 4, 5, 6
- inflammatory index and study cohort: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date